Heparin-Induced Thrombocytopenia — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Discontinue all heparin; once the residual heparin effect on aPTT has declined, commence reduced-dose argatroban and titrate using aPTT
The correct answer is B. Confirmed immune-mediated HIT is intensely prothrombotic, so all heparin—including flushes and heparin-coated sources—must be stopped and therapeutic non-heparin anticoagulation started; thrombocytopenia alone is not a reason to observe. Argatroban is a licensed direct thrombin inhibitor suitable here. Because he is critically ill following cardiac surgery, the SmPC supports starting at 0.5 microgram/kg/min, after allowing residual heparin-related aPTT prolongation to decline, then titrating to 1.5–3.0 times baseline without exceeding 100 seconds. Warfarin must not be initiated during acute thrombocytopenia because rapid protein C depletion may cause microvascular thrombosis and venous limb gangrene. Prophylactic platelet transfusion is generally avoided; it may be considered for clinically important bleeding or an urgent invasive procedure. Reducing rather than stopping heparin leaves the pathogenic stimulus in place.
Reference: Ethypharm UK Ltd. Exembol 1 mg/ml Solution for Infusion, Summary of Product Characteristics, sections 4.1–4.4; text revised 31 October 2024. https://www.medicines.org.uk/emc/product/16026/smpc